Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Colin A. Hutchison"'
Autor:
Alejandra P. Molano, Colin A. Hutchison, Ricardo Sanchez, Angela S. Rivera, Giancarlo Buitrago, María P. Dazzarola, Mario Munevar, Mauricio Guerrero, Jasmín I. Vesga, Mauricio Sanabria
Publikováno v:
Kidney Medicine, Vol 4, Iss 4, Pp 100431- (2022)
Rationale & Objective: This study investigated the effects on patients’ outcomes of using medium cutoff (MCO) versus high-flux (HF) dialysis membranes. Study Design: A retrospective, observational, multicenter, cohort study. Setting & Participants:
Externí odkaz:
https://doaj.org/article/406fa287fce349a6a2b1f8ac17b67020
Autor:
Lakhvir K Assi, Natasha McIntyre, Simon Fraser, Scott Harris, Colin A Hutchison, Chris W McIntyre, Paul Cockwell, Maarten W Taal
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0129980 (2015)
A major component of increased mortality risk in people with chronic kidney disease (CKD) is associated with non-traditional cardiovascular risk factors including markers of inflammation. We studied whether a novel marker of systemic inflammation, el
Externí odkaz:
https://doaj.org/article/8c57ca8f454a4b0c89a4fa21a9d53c2a
Autor:
Lakhvir K Assi, Natasha McIntyre, Simon Fraser, Scott Harris, Colin A Hutchison, Chris W McIntyre, Paul Cockwell, Maarten W Taal
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141404 (2015)
Externí odkaz:
https://doaj.org/article/c555b0ae15bd4231a184c325e7ff1013
Autor:
Julie Wessels, Markus Storr, Colin A. Hutchison, Mark Jesky, Paul Cockwell, Lesley Fifer, Christopher G. Winearls, Nils Heyne, Veronica Moroz, Julian D. Gillmore, Arthur R. Bradwell, Mark Cook, Katja Weisel
Publikováno v:
The Lancet Haematology. 6:e217-e228
Summary Background In multiple myeloma, severe acute kidney injury due to myeloma cast nephropathy is caused by pathogenic free light chain immunoglobulin in serum. High cutoff haemodialysis (HCO-HD) can remove large quantities of free light chain im
Autor:
Manish Kaushik, Peter Stenvinkel, Kianoush Kashani, Ziad A. Massy, Li Zuo, Faeq Husain-Syed, Thiago Reis, Peter J. Blankestijn, Hideki Kawanishi, Colin A. Hutchison, Raymond Vanholder, Laurent Juillard, Claudio Ronco, Mario Cozzolino, Mitchell H. Rosner, Tammy L. Sirich
Publikováno v:
Clinical Journal of the American Society of Nephrology
Clinical Journal of the American Society of Nephrology, American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
Clin J Am Soc Nephrol
Clinical Journal of the American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
Clinical Journal of the American Society of Nephrology, American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
Clin J Am Soc Nephrol
Clinical Journal of the American Society of Nephrology, 2021, pp.CJN.02660221. ⟨10.2215/cjn.02660221⟩
International audience; Advances in our understanding of uremic retention solutes, and improvements in hemodialysis membranes and other techniques designed to remove uremic retention solutes, offer opportunities to readdress the definition and classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a347b62e193679a3fa2a88d48244a0b
https://www.hal.inserm.fr/inserm-03452101/document
https://www.hal.inserm.fr/inserm-03452101/document
Autor:
Mark K Tiong, Elaine M. Pascoe, Anne Heath, Elizabeth G. Ryan, Carmel M. Hawley, Peter F Mount, David W. Johnson, Shaundeep Sen, Peta-Anne Paul-Brent, Muh Geot Wong, Colin A. Hutchison, Yeoungjee Cho, Edward R Smith, Tim D. Hewitson, Meg Jardine, Nigel D Toussaint, Liza A. Vergara, Matthew A Roberts, Rathika Krishnasamy, Craig Nelson
Publikováno v:
Hemodialysis International.
Introduction: Hemodialysis (HD) with medium cut-off (MCO) dialyzers may expand molecular clearance, predominantly larger middle molecules (molecular weight 25–60 kDa). However, the impact of MCO dialyzers on long-term clearance of various other com
Autor:
Colin A. Hutchison, Adriana M Suarez, Rafael M. Sanabria, Jasmin Vesga, Ricardo Sánchez, J.G. Ariza
Publikováno v:
Nephron. 145(2)
Introduction: Expanded hemodialysis (HDx) effectively removes large middle molecular uremic toxins (>25 kDa) while still retaining albumin, potentially reducing their adverse effects. We compare the clinical laboratory parameters, hospitalization rat
Autor:
Martin Wolley, Colin A. Hutchison
Publikováno v:
Nephrology Dialysis Transplantation
Patients with end-stage kidney disease (ESKD) on maintenance hemodialysis are subject to a high burden of inflammation and cardiovascular disease, driven at least in part by retention of uremic solutes. Existing dialysis technologies using high-flux
Publikováno v:
The International journal of pharmacy practiceReferences. 28(6)
Objective Acute kidney injury (AKI) prevention strategies for community-acquired AKI associated with severe acute illness have received attention in recent years. The objective of this study was to evaluate a community pharmacist AKI education progra